IRON Valuation

Disc Medicine Inc

Add to Watchlist

Advanced Chart

61.495

+0.705(1.160%)1D

Overview
Forecast
Valuation
Earnings

IRON Relative Valuation

IRON's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, IRON is overvalued; if below, it's undervalued.

Historical Valuation

Disc Medicine Inc (IRON) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -10.85. The fair price of Disc Medicine Inc (IRON) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：61.49

Fair

-9.82

Trailing

Forward

-7.24

EV/EBITDA

Disc Medicine Inc. (IRON) has a current EV/EBITDA of -7.24. The 5-year average EV/EBITDA is -6.63. The thresholds are as follows: Strongly Undervalued below -10.29, Undervalued between -10.29 and -8.46, Fairly Valued between -4.80 and -8.46, Overvalued between -4.80 and -2.97, and Strongly Overvalued above -2.97. The current Forward EV/EBITDA of -7.24 falls within the Historic Trend Line -Fairly Valued range.

-6.37

EV/EBIT

Disc Medicine Inc. (IRON) has a current EV/EBIT of -6.37. The 5-year average EV/EBIT is -7.39. The thresholds are as follows: Strongly Undervalued below -12.00, Undervalued between -12.00 and -9.70, Fairly Valued between -5.08 and -9.70, Overvalued between -5.08 and -2.77, and Strongly Overvalued above -2.77. The current Forward EV/EBIT of -6.37 falls within the Historic Trend Line -Fairly Valued range.

6163.31

Disc Medicine Inc. (IRON) has a current PS of 6163.31. The 5-year average PS is 451.38. The thresholds are as follows: Strongly Undervalued below -2725.91, Undervalued between -2725.91 and -1137.26, Fairly Valued between 2040.03 and -1137.26, Overvalued between 2040.03 and 3628.67, and Strongly Overvalued above 3628.67. The current Forward PS of 6163.31 falls within the Strongly Overvalued range.

-12.39

P/OCF

Disc Medicine Inc. (IRON) has a current P/OCF of -12.39. The 5-year average P/OCF is -10.66. The thresholds are as follows: Strongly Undervalued below -17.32, Undervalued between -17.32 and -13.99, Fairly Valued between -7.33 and -13.99, Overvalued between -7.33 and -4.00, and Strongly Overvalued above -4.00. The current Forward P/OCF of -12.39 falls within the Historic Trend Line -Fairly Valued range.

-11.74

P/FCF

Disc Medicine Inc. (IRON) has a current P/FCF of -11.74. The 5-year average P/FCF is -12.53. The thresholds are as follows: Strongly Undervalued below -21.13, Undervalued between -21.13 and -16.83, Fairly Valued between -8.23 and -16.83, Overvalued between -8.23 and -3.93, and Strongly Overvalued above -3.93. The current Forward P/FCF of -11.74 falls within the Historic Trend Line -Fairly Valued range.

Disc Medicine Inc (IRON) has a current Price-to-Book (P/B) ratio of 3.47. Compared to its 3-year average P/B ratio of 3.16 , the current P/B ratio is approximately 10.10% higher. Relative to its 5-year average P/B ratio of 3.16, the current P/B ratio is about 10.10% higher. Disc Medicine Inc (IRON) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -6.67%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -6.67% , the current FCF yield is about -100.00% lower.

3.47

P/B

Median3y

3.16

Median5y

3.16

-6.41

FCF Yield

Median3y

-6.67

Median5y

-6.67

Competitors Valuation Multiple

The average P/S ratio for IRON's competitors is 3.44, providing a benchmark for relative valuation. Disc Medicine Inc Corp (IRON) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

ANI Pharmaceuticals Inc

Recursion Pharmaceuticals Inc

Apogee Therapeutics Inc

Loss

2.26B

ADPT.O

Adaptive Biotechnologies Corp

Performance Decomposition

Market capitalization of IRON increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of IRON in the past 1 year is driven by Unknown.